HCV genotype 3 is associated with a higher hepatocellular carcinoma incidence in patients with ongoing viral C cirrhosis
暂无分享,去创建一个
M. Ziol | E. Vicaut | D. Roulot | N. Ganne-Carrié | J. Trinchet | M. Beaugrand | E. Gordien | M. Aout | G. N’kontchou | V. Grando-Lemaire | G. Nkontchou | A. Mahmoudi | V. Grando-Lemaire | M. Lhabadie | Y. Baazia | I. Baghad | Emmanuel Gordien | Eric Vicaut
[1] L. Babiuk,et al. Hepatitis C virus genotype-3a core protein enhances sterol regulatory element-binding protein-1 activity through the phosphoinositide 3-kinase-Akt-2 pathway. , 2010, The Journal of general virology.
[2] Pierre Bedossa,et al. Impact of peginterferon and ribavirin therapy on hepatocellular carcinoma: incidence and survival in hepatitis C patients with advanced fibrosis. , 2010, Journal of hepatology.
[3] B. McMahon,et al. Adverse outcomes in Alaska natives who recovered from or have chronic hepatitis C infection. , 2010, Gastroenterology.
[4] P. Francioli,et al. Genotype 3 is associated with accelerated fibrosis progression in chronic hepatitis C. , 2009, Journal of hepatology.
[5] Soo-Ho Choi,et al. Non‐structural 5A protein of hepatitis C virus induces a range of liver pathology in transgenic mice , 2009, The Journal of pathology.
[6] William M. Lee,et al. Evolution of hepatic steatosis in patients with advanced hepatitis C: Results from the hepatitis C antiviral long‐term treatment against cirrhosis (HALT‐C) trial , 2009, Hepatology.
[7] M. Mondelli,et al. Hepatitis C virus genotype 1b as a risk factor for hepatocellular carcinoma development: a meta-analysis. , 2009, Journal of hepatology.
[8] Y. Shin,et al. Liver X receptor mediates hepatitis B virus X protein–induced lipogenesis in hepatitis B virus–associated hepatocellular carcinoma , 2009, Hepatology.
[9] V. Paradis,et al. Hepatocellular carcinomas in patients with metabolic syndrome often develop without significant liver fibrosis: A pathological analysis , 2009, Hepatology.
[10] Chien-Hua Chen,et al. Clinical significance of elevated alpha-fetoprotein (AFP) in chronic hepatitis C without hepatocellular carcinoma. , 2008, Hepato-gastroenterology.
[11] J. Pawlotsky,et al. Morphological changes in intracellular lipid droplets induced by different hepatitis C virus genotype core sequences and relationship with steatosis , 2008, Hepatology.
[12] M. Manns,et al. Increased risk of hepatocellular carcinoma among patients with hepatitis C cirrhosis and diabetes mellitus , 2008, Hepatology.
[13] F. Roudot-thoraval,et al. Daily cannabis use: a novel risk factor of steatosis severity in patients with chronic hepatitis C. , 2008, Gastroenterology.
[14] R. Jhaveri,et al. Specific polymorphisms in hepatitis C virus genotype 3 core protein associated with intracellular lipid accumulation. , 2008, The Journal of infectious diseases.
[15] J. Pekow,et al. Hepatic steatosis is associated with increased frequency of hepatocellular carcinoma in patients with hepatitis C‐related cirrhosis , 2007, Cancer.
[16] K. Koike. Hepatitis C virus contributes to hepatocarcinogenesis by modulating metabolic and intracellular signaling pathways , 2007, Journal of gastroenterology and hepatology.
[17] L. Babiuk,et al. Up-regulation of fatty acid synthase promoter by hepatitis C virus core protein: genotype-3a core has a stronger effect than genotype-1b core. , 2007, Journal of hepatology.
[18] A. Mangia,et al. Sustained virological response to interferon‐α is associated with improved outcome in HCV‐related cirrhosis: A retrospective study , 2007, Hepatology.
[19] C. Datz,et al. Liver microsomal triglyceride transfer protein is involved in hepatitis C liver steatosis. , 2006, Gastroenterology.
[20] P. Couzigou,et al. Changing of hepatitis C virus genotype patterns in France at the beginning of the third millenium: The GEMHEP GenoCII Study , 2005, Journal of viral hepatitis.
[21] Francesco Donato,et al. Hepatocellular carcinoma in cirrhosis: incidence and risk factors. , 2004, Gastroenterology.
[22] J. Pawlotsky,et al. Effect of antiviral treatment on evolution of liver steatosis in patients with chronic hepatitis C: indirect evidence of a role of hepatitis C virus genotype 3 in steatosis , 2004, Gut.
[23] K. Eguchi,et al. Hepatic steatosis is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis C virus infection , 2003, Cancer.
[24] M. Honda,et al. Steatosis and liver cancer in transgenic mice expressing the structural and nonstructural proteins of hepatitis C virus. , 2002, Gastroenterology.
[25] L Pagliaro,et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. , 2001, Journal of hepatology.
[26] V. P. Chacko,et al. Hepatic hyperplasia in noncirrhotic fatty livers: is obesity-related hepatic steatosis a premalignant condition? , 2001, Cancer research.
[27] M. Gambardella,et al. Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity , 2001, Hepatology.
[28] K. Koike,et al. Oxidative stress in the absence of inflammation in a mouse model for hepatitis C virus-associated hepatocarcinogenesis. , 2001, Cancer research.
[29] K. Abid,et al. Hepatocyte steatosis is a cytopathic effect of hepatitis C virus genotype 3. , 2000, Journal of hepatology.
[30] S. Chevret,et al. Hepatocellular carcinoma without cirrhosis in the West: epidemiological factors and histopathology of the non-tumorous liver. Groupe d'Etude et de Traitement du Carcinome Hépatocellulaire. , 1999, Journal of hepatology.
[31] Yoshiharu Matsuura,et al. The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice , 1998, Nature Medicine.
[32] V. Paradis,et al. In situ detection of lipid peroxidation in chronic hepatitis C: correlation with pathological features. , 1997, Journal of clinical pathology.